
Work Here?
Work Here?
Work Here?
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$64.9M
Headquarters
Waltham, Massachusetts
Founded
2019
Linus Health provides a digital cognitive care platform for the early detection and intervention of Alzheimer's disease and other dementias. It uses AI to enhance cognitive assessments, combining traditional tests with a process-based neurological analysis, and its main product is an iPad-based platform with quick administration, automated scoring, multi-language support, clinical decision support, and personalized patient plans. Its flagship DCTclock upgrades the clock-drawing test with AI and is based on long-running research from MIT and Lahey. The goal is to enable earlier detection and timely interventions to improve patient outcomes as dementia prevalence rises worldwide.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$64.9M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Health, dental, vision & life insurance
Unlimited PTO
Parental leave
401K with 6% match
Performance Bonus
Employee Stock Purchase Plan
Work From Home Policy
Employee Referral Incentive program
Company Social Outings
Linus Health receives Provista contract for early cognitive detection solution. Supplier agreement expands access for physician practices to AI-driven tools for proactive brain health /PRNewswire/ - Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, announced it has secured a first-of-its-kind supplier agreement with Provista, a leading group purchasing organization known for its innovative and cost-effective solutions. The agreement expands access to Linus Health's digital brain health solutions for Provista physician practice clients. Linus Health is the first AI-driven brain health solution selected by Provista, reflecting the growing importance of early, technology-enabled detection and management of cognitive decline across the care continuum. Through this new agreement, Provista clients gain increased access to Linus Health's suite of AI-powered solutions, including the Core Cognitive Evaluation (CCE) and Anywhere, Linus Health'sremote assessment tool. These AI-enabled solutions complement Provista's core offerings in healthcare supply chain procurement, market intelligence, strategic analytics, and consulting, helping providers enhance preventive care and patient outcomes with early, objective insights into brain health. "This agreement marks a significant milestone for Linus Health," said Leah Ray, president of US Healthcare & chief customer officer, Linus Health. "Being chosen by Provista underscores both the maturity of our platform and the growing recognition that cognitive health is a vital part of preventive care. Through Provista's network of physician practices, we can empower primary care providers to detect cognitive changes earlier, improve patient outcomes, and redefine the standard of care for brain health." "Digital health innovation is moving from concept to core infrastructure in healthcare," added Ray. "Our agreement with Provista will help clinicians incorporate brain health assessments into routine preventive care and reach more patients nationwide." About Linus Health Linus Health is a Boston-based digital health company focused on transforming brain health for people across the world. By advancing how we detect and address cognitive and brain disorders - leveraging cutting-edge neuroscience, clinical expertise, and artificial intelligence - our goal is to enable a future where people can live longer, happier, and healthier lives with better brain health. Linus Health's digital cognitive assessment platform delivers a proven, practical means of enabling early detection; empowers providers with actionable clinical insights; and supports individuals with personalized action plans. We are proud to partner with leading healthcare delivery organizations, research institutions, and life sciences companies to accelerate more proactive intervention and personalized care in brain health. To learn more about our practical solutions for proactive brain health(R), visitwww.linushealth.com or follow us on LinkedIn. Media Contact Supreme Communications for Linus Health [emailprotected] SOURCE Linus Health
Linus Health adds deep clinical and Public Health experience with appointment of Julie Wood, MD, MPH, FAAFP, as Senior Medical Director, Clinician Engagement. BOSTON, Dec. 15, 2025 /PRNewswire/ - Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, today announced the appointment of former Academy of Family Physicians (AAFP) executive Julie Wood, MD, MPH, FAAFP, as Linus Health Senior Medical Director, Clinician Engagement. Wood brings more than two decades of clinical, public health, and primary care leadership experience to Linus Health, along with extensive expertise in clinician education, quality improvement, and large-scale practice transformation. A practicing family physician for nearly 20 years, Wood has held roles spanning research, science, clinical strategy, and population health. Most recently, she served as Senior Vice President for Science and Clinical Strategy at AAFP, where she oversaw scientific research, public health initiatives, interprofessional collaboration, and the development of clinical and policy resources for family physicians nationwide. Her career includes experience guiding primary care teams through the adoption of new clinical models, implementing evidence-based resources, and improving workflows to support patient-centered care. In her new role at Linus Health, Wood will lead clinician engagement strategies as health systems adopt digital cognitive assessments and AI-enabled tools to support earlier detection of cognitive impairment and better-informed care pathways. She will work closely with clinical leaders across the country to support implementation, training, and continuous quality improvement. "Primary care teams support individuals and families across every stage of life, and they need practical tools that fit clinical workflows and reflect real-world care priorities," Wood said. "My new role at Linus Health provides a meaningful opportunity to partner with clinicians to help them incorporate AI-enabled cognitive assessments into their workflows to support proactive brain health. As a family physician myself, I look forward to spreading the word about how Linus Health tools elevate the quality of everyday decision making, strengthen confidence in identifying cognitive change, and support earlier and more effective intervention for patients who may be at risk for decline." Wood joins Linus Health at a time of accelerating demand for efficient, scalable approaches to cognitive assessment as new disease-modifying treatments enter the Alzheimer's care landscape. Health systems are seeking solutions that can capture subtle cognitive and functional patterns, streamline evaluation within primary care, and reduce delays that have historically stretched diagnostic timelines to months or years. Linus Health's platform supports this shift by enabling rapid, structured assessments, strengthening care teams' ability to identify impairment earlier, and expanding capacity across diverse clinical settings, including rural and high-volume practices. These advances help create a clearer pathway from initial concern to timely treatment planning while supporting more consistent and equitable access to brain health evaluation. "We welcome Dr. Wood at a moment when providers across the country are working to integrate new approaches that support earlier identification of cognitive change and more efficient diagnostic pathways," said David Bates, PhD, CEO and co-founder of Linus Health. "Her extensive experience in primary care, public health, and clinician engagement will be an asset as we accelerate the adoption of AI-enabled cognitive assessments that support earlier detection, improve care pathways, and enhance clinical readiness for new treatment options. Her leadership will supercharge the integration of our AI-powered, evidence-based digital cognitive health tools that deliver objective, personalized insights." Wood is board-certified by the American Board of Family Medicine, having earned her medical degree from the University of Missouri - Kansas City School of Medicine and a Master of Public Health from the University of West Florida. She has been recognized nationally for her contributions to family medicine, public health, and clinical education, bringing a strong commitment to advancing care quality and health equity. About Linus Health Linus Health is a Boston-based digital health company focused on transforming brain health for people around the world. By advancing how The AI Journal Ltd. detect and address cognitive and brain disorders leveraging cutting-edge neuroscience, clinical expertise, and artificial intelligence, the company's goal is to enable a future where people can live longer, healthier lives with better brain health. Linus Health's digital cognitive assessment platform delivers a practical means of enabling early detection, empowers providers and researchers with actionable insights, and supports individuals with personalized action plans. The company partners with leading healthcare delivery organizations, research institutions, and life sciences companies to accelerate more proactive intervention and personalized care in brain health. To learn more about its practical solutions for proactive brain health(R), visit www.linushealth.com or follow Linus Health on LinkedIn. Media Contact: Tara Stultz (Supreme Communications for Linus Health) [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/linus-health-adds-deep-clinical-and-public-health-experience-with-appointment-of-julie-wood-md-mph-faafp-as-senior-medical-director-clinician-engagement-302642352.html SOURCE Linus Health
League has raised over $285 million in venture capital funding to date, powering the digital experiences for some of healthcare's most trusted brands, including Highmark Health, Manulife, Medibank, and Shoppers Drug Mart.
BOSTON, July 22, 2025 /PRNewswire/ - Linus Health, which is revolutionizing brain health with science-driven digital solutions, will present two oral presentations and eight posters at the Alzheimer's Association International Conference(R) (AAIC(R)) 2025, taking place July 27-31 in Toronto and virtually.
Linus Health Launches AI-Powered Remote Assessment to Combat Undetected Cognitive Impairment. by Jasmine Pennic 03/21/2025 Leave a Comment. What You Should Know: – Linus Health has introduced Anywhere for Health Systems™, an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia. – The new solution empowers health systems to conduct accurate and efficient cognitive evaluations remotely, significantly improving early detection rates and streamlining patient care.Delivering Clinical-Grade Cognitive Assessments RemotelyThe alarming statistic that 92% of MCI cases go undetected highlights a major gap in current healthcare practices. Traditional MCI detection methods, involving in-person screenings and lengthy neuropsychological evaluations, are often time-consuming and resource-intensive, placing a strain on already overburdened clinicians.Anywhere for Health Systems™ offers a solution by providing a convenient and rapid assessment that patients or their care partners can administer from home via laptop, tablet, or phone, at the request of their primary care provider (PCP). This FDA Class II medical device utilizes a peer-reviewed battery of tests to assess four critical cognitive domains.Anywhere for Health Systems™ complements Linus Health’s broader suite of cognitive health solutions, including Radar and a portfolio of digital cognitive assessments and personalized action plans. Linus Health collaborates with health systems to tailor workflows and optimize patient and provider experiences.“This self-administered test is the solution healthcare systems have been looking for,” said John Showalter, MD, MSIS, chief strategy and product officer at Linus Health
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$64.9M
Headquarters
Waltham, Massachusetts
Founded
2019
Find jobs on Simplify and start your career today